Journal
IMMUNOBIOLOGY
Volume 216, Issue 9, Pages 988-996Publisher
ELSEVIER GMBH
DOI: 10.1016/j.imbio.2011.03.011
Keywords
CYP24A1; 1,25-Dihydroxy vitamin D3; Dendritic cells; Macrophages; Nitric oxide; TLR-4; Innate immunity
Categories
Funding
- Dairy Farmers of Canada
- NSERC
- Wilson fellowship
- CIHR
Ask authors/readers for more resources
The vitamin D metabolite, 1,25-(OH)(2)D-3, binds the vitamin D receptor (VDR) to exert its regulatory effects at the transcription level. VDR is expressed in professional antigen-presenting cells (pAPCs), such as macrophages (Mo) and dendritic cells (DCs). We show for the first time that the 24-hydroxylase enzyme is activated in bone marrow-derived dendritic cell (BMDC), due to 1,25(OH)(2)D-3 stimulation which resulted in the induction of its gene, CYP24A1. Furthermore, we provide evidence that the influence of 1,25-(OH)(2)D-3 on TLR-4-L-induced activation of pAPC is dependent on the order of VDR and TLR-4 engagement. Thus, pre-treatment of pAPC with1.25-(OH)(2)D-3 partially inhibited LPS-induced nitric oxide (NO) production. However, these inhibitory effects were not observed when LPS and 1.25-(OH)(2)D-3 were added simultaneously or when LPS preceded 1,25-(OH)(2)D-3. Moreover, we found that 1,25-(OH)(2)D-3 pretreatment of pAPCs did not cause general suppression since it interfered with NO levels but not with the cytokines IL-6 or TNF-alpha. Consequently, engagement of VDR by 1.25-(OH)(2)D-3 can partially interfere with TLR-4-L-induced activation of pAPCs only when it occurs before TLR-4 stimulation. (C) 2011 Elsevier GmbH. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available